Background Current guidelines for the treatment of asthma and chronic obstructive
pulmonary disease overlap (ACO) recommend initial treatment using inhaled corticosteroids …

Objective To review the latest literature on management approaches to patients with asthma
chronic obstructive pulmonary disease (COPD) overlap (ACO). Data Sources Studies and …

Objective: Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is of
increasing interest because ACO patients have significantly worse outcomes, leading to …

Objective To determine the safety and effectiveness of current pharmacotherapies consisting
of long-acting beta2-agonist (LABA) and/or inhaled corticosteroids (ICS) in patients with …

abstract Asthma and COPD overlap (ACO) is an important clinical phenotype, due to the low-
health-related quality of life (QOL), rapid decline in lung function, frequent exacerbation, and …

Introduction: Inhaled corticosteroids (ICS)(in fixed combinations with long-acting β2-agonists
[LABAs]) are frequently prescribed for patients with chronic obstructive pulmonary disease …

Purpose A systematic review and meta-analysis to determine the efficacy of long-acting
muscarinic antagonist (LAMA) in patients with asthma-COPD overlap (ACO) was conducted …

Background Based on current guidelines, more research is urgently needed to guide
appropriate treatment for patients with asthma-chronic obstructive pulmonary disease …

Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is a term applied to
patients with clinical features of both asthma and COPD. ACO has been associated with …

Background Asthma and chronic obstructive pulmonary disease (COPD) overlap syndrome
(ACOS) is an increasingly recognized phenotype. Few randomized clinical trials have been …